1. Study design of the eleven included trials.
Study | Number/design/clinical Setting | Mean age (years) | % Female | Magnesium dose and route of administration | Frequency of administration | Treatment and assessment periods (days) | Washout period (days) | Comparator |
Cohen‐Hagai 2018 | N = 29 Parallel Liver cirrhosis |
62.0 | 41.4% | 520 mg magnesium oxide tablets (315 mg elemental Mg) | Once daily | Treatment 56 Assessment 56 |
Not applicable | Matched placebo tablet |
Dahle 1995 | N = 73 Parallel Pregnancy |
Not given (child‐ bearing years) |
100% | 5 mmol combination Mg lactate + Mg citrate (122 mg elemental Mg) taken orally | Once each morning and twice each evening | Treatment 21 Assessment 21 |
Not applicable | Matched placebo tablet |
Frusso 1999 | N = 45 Cross‐over Idiopathic |
61.6 | 73.3% | Mg citrate 900 mg tablet (100 mg elemental Mg) taken orally | Twice daily | Treatment 28 Assessment 28 |
28 | Matched placebo tablet |
Garrison 2011a | N = 46 Parallel Idiopathic |
69.3 | 69.6% | 20 mmol Mg sulphate (486 mg elemental Mg) given intravenously | Once daily over 4 hrs on 5 consecutive days | Treatment 5 Assessment 90 |
Not applicable | Matched placebo solution |
Nygaard 2008 | N = 45 Parallel Pregnancy |
30.9 | 100% | Mg lactate and Mg citrate chewable tablets containing 122 mg elemental Mg taken orally | Once each morning and twice each evening | Treatment 14 Assessment 14 |
Not applicable | Matched placebo tablet |
Roffe 2002 | N = 73 Cross‐over Idiopathic |
62.9 | 54.3% | 1830 mg of tri‐magnesium dicitrate powder (300 mg elemental Mg) poured from a sachet into a glass of water taken orally | Once each evening | Treatment 42 Assessment during last 28 days of treatment |
First 14 days of second treatment period considered as washout |
Matched placebo powder |
NCT00963638 | N = 40 Parallel Idiopathic |
66.6 | 57.5% | Slow release tablet of Mg lactate containing 84 mg of elemental Mg taken orally |
2 tablets twice daily | Treatment 30 Assessment 30 |
Not applicable | Matched placebo tablet |
Sohrabvand 2006 | N = 84 Parallel Pregnancy |
Not given (child‐ bearing years) |
100% | 7.5 mmol magnesium aspartate (182 mg elemental Mg) taken orally. Unclear if tablet or powder / solution |
Twice daily | Treatment 14 Assessment 28 |
Not applicable | 3 different comparators 1) No treatment 2) 500 mg calcium carbonate tablet once daily 3)100 mg of thiamine (vit B₁) plus 40 mg of pyridoxine (vit B₆) once daily |
Shahraki 2006 | N = 120 Parallel Pregnancy |
29.2 | 100% | 8 cc of an 8% milk of magnesium suspension (267.2 mg of elemental magnesium) | 3 times a day | Treatment 45 Assessment 90 |
Not applicable | 2 different comparators 1) 100 mg of vitamin E once daily 2) 500 mg of calcium carbonate once daily |
Supakatisant 2015 | N = 86 Parallel Pregnancy |
28.7 | 100% | Mg bisglycinate tablets containing 100 mg of elemental mg taken orally | 3 times a day | Treatment 28 Assessment 28 |
Not applicable | Matched placebo tablets |
Roguin Maor 2017 | N = 94 Parallel Idiopathic |
64.9 | 63% | 865 mg magnesium oxide capsules (520 mg elemental Mg) | Once daily at bedtime | Treatment 28 Assessment 28 |
Not applicable | Matched placebo capsules |
vit B₁: vitamin B₁